Stockreport

Fibrocell to Present at 21st Annual BIO CEO & Investor Conference

FIBROCELL SCIENCE INC COMMON  (FCSC) 
NASDAQ:AMEX Investor Relations: fibrocell.com
PDF EXTON, Pa., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapie [Read more]